AU2002367951A8 - The use of the inhibitor transmitter of gamma-aminobutyric acid (gaba) in the manufacture of analgesic - Google Patents
The use of the inhibitor transmitter of gamma-aminobutyric acid (gaba) in the manufacture of analgesicInfo
- Publication number
- AU2002367951A8 AU2002367951A8 AU2002367951A AU2002367951A AU2002367951A8 AU 2002367951 A8 AU2002367951 A8 AU 2002367951A8 AU 2002367951 A AU2002367951 A AU 2002367951A AU 2002367951 A AU2002367951 A AU 2002367951A AU 2002367951 A8 AU2002367951 A8 AU 2002367951A8
- Authority
- AU
- Australia
- Prior art keywords
- gaba
- analgesic
- gamma
- inhibitor
- transmitter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 title 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02111772A CN1382441A (en) | 2002-05-21 | 2002-05-21 | Application of gammalon transporter inhibitor in preparing analgesic |
| CN02111772.1 | 2002-05-21 | ||
| PCT/CN2002/000846 WO2003097023A1 (en) | 2002-05-21 | 2002-11-26 | The use of the inhibitor transmitter of ϝ-aminobutyric acid (gaba) in the manufacture of analgesic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002367951A1 AU2002367951A1 (en) | 2003-12-02 |
| AU2002367951A8 true AU2002367951A8 (en) | 2003-12-02 |
Family
ID=4741737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002367951A Abandoned AU2002367951A1 (en) | 2002-05-21 | 2002-11-26 | THE USE OF THE INHIBITOR TRANSMITTER OF Gamma-AMINOBUTYRIC ACID (GABA) IN THE MANUFACTURE OF ANALGESIC |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1382441A (en) |
| AU (1) | AU2002367951A1 (en) |
| WO (1) | WO2003097023A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101711862B (en) * | 2008-10-08 | 2012-07-18 | 中国科学院上海生命科学研究院 | A drug target related to inflammatory disease and its application |
| CN102399275A (en) * | 2011-11-21 | 2012-04-04 | 中国科学院微生物研究所 | A gamma-aminobutyric acid transporter, its coding gene and application |
| JP6301920B2 (en) * | 2013-05-27 | 2018-03-28 | 国立大学法人 岡山大学 | Pain medicine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU552050B2 (en) * | 1981-05-26 | 1986-05-22 | Smithkline Beckman Corporation | N-substituted azeheterocyclic carboxylic acids and their esters |
| DK288385D0 (en) * | 1985-06-26 | 1985-06-26 | Novo Industri As | AMINO ACID DERIVATIVES |
| DK165692C (en) * | 1986-01-07 | 1993-11-08 | Novo Nordisk As | PHENYLBUTEN DERIVATIVES, PROCEDURES FOR PREPARING THEM, PHARMACEUTICAL PREPARATIONS CONTAINING THESE, AND USING THESE TO PREPARE A MEDICINE USED TO INHIBIT GABA ADMISSION |
| DK93791D0 (en) * | 1991-05-17 | 1991-05-17 | Novo Nordisk As | NEW HETEROCYCLIC CARBOXYLIC ACIDS |
| DK74593D0 (en) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | NOVEL HETEROCYCLIC CHEMISTRY |
| DK74693D0 (en) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | NOVEL HETEROCYCLIC CHEMISTRY |
-
2002
- 2002-05-21 CN CN02111772A patent/CN1382441A/en active Pending
- 2002-11-26 WO PCT/CN2002/000846 patent/WO2003097023A1/en not_active Application Discontinuation
- 2002-11-26 AU AU2002367951A patent/AU2002367951A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003097023A1 (en) | 2003-11-27 |
| CN1382441A (en) | 2002-12-04 |
| AU2002367951A1 (en) | 2003-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003221786A1 (en) | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors | |
| EP1660017A4 (en) | Amino acid prodrugs | |
| AU2003210824A8 (en) | (oxime)carbamoyl fatty acid amide hydrolase inhibitors | |
| AP2005003227A0 (en) | Synergistic combination of an alpha-2-delta ligandand a PDEV inhibitor for use in the treatment of pain. | |
| AU2003294056A1 (en) | Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses | |
| AU2003238042A1 (en) | Cyclooxygenase-2 inhibitors | |
| PL374279A1 (en) | Nitrooxyderivatives of cyclooxygenase-2 inhibitors | |
| AU2003233426A1 (en) | Corrosion inhibitor | |
| AU2003235798A1 (en) | Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation | |
| AU2003290735A1 (en) | Inhibitors of monoamine uptake | |
| IL162932A0 (en) | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 | |
| AU2003206945A1 (en) | Use of proteinase inhibitors in the treatment of autoimmune diseases | |
| AU2002367951A8 (en) | The use of the inhibitor transmitter of gamma-aminobutyric acid (gaba) in the manufacture of analgesic | |
| AU2002324734A1 (en) | Borinic acid protease inhibitors | |
| AU2003241400A8 (en) | Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors | |
| AU2003300800A1 (en) | Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors | |
| AU2003277878A1 (en) | Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors | |
| AU2003242559A1 (en) | Alkylaminosiloxanes as corrosion inhibitors | |
| GB0230240D0 (en) | Removal of an acid | |
| EP1622603A4 (en) | Phenolic acid salts of gabapentin in solid dosage forms and methods of use | |
| AU2002253633A1 (en) | 20-hydroxyeicosatetraenoic acid production inhibitors | |
| GB0214711D0 (en) | Novel phosphonocarboxylic acid esters | |
| GB2393029B (en) | Polarised display | |
| AU2003251456A1 (en) | N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides | |
| GB0210428D0 (en) | Calmag JG - magnetic in-line pushfit scale inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |